- call +1-201-465-4211
- email sales@mrinsights.biz
Anticancer Drugs are used to treat malignancies, or cancerous growths. Drug therapy may be used alone, or in combination with other treatments such as surgery or radiation therapy.
Scope of the Report:
Anticancer drugs are agents that demonstrate activity against malignant disease. They include alkylating agents, antimetabolites, natural products, and hormones, as well as a variety of other chemicals that do not fall within these discrete classes but are capable of preventing the replication of cancer cells and thus are used in the treatment of cancer.
The worldwide market for Anticancer Drug is expected to grow at a CAGR of roughly 6.3% over the next five years, will reach 141800 million US$ in 2023, from 98300 million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Anticancer Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Roche
Celgene
Pfizer
Bristol-Myers Squibb
Novartis
AstraZeneca
Teva Pharmaceuticals
Bayer
GlaxoSmithKline
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Targeted Drugs
Cytotoxic Drugs
Hormonal Drugs
Market Segment by Applications, can be divided into
Immunotherapy
Targeted Therapy
Chemotherapy
Hormonal Therapy
Others
There are 15 Chapters to deeply display the global Anticancer Drug market.
Chapter 1, to describe Anticancer Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anticancer Drug, with sales, revenue, and price of Anticancer Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anticancer Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anticancer Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anticancer Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Anticancer Drug Introduction
1.2 Market Analysis by Type
1.2.1 Targeted Drugs
1.2.2 Cytotoxic Drugs
1.2.3 Hormonal Drugs
1.3 Market Analysis by Applications
1.3.1 Immunotherapy
1.3.2 Targeted Therapy
1.3.3 Chemotherapy
1.3.4 Hormonal Therapy
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Anticancer Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Celgene
2.2.1 Business Overview
2.2.2 Anticancer Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Celgene Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Anticancer Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bristol-Myers Squibb
2.4.1 Business Overview
2.4.2 Anticancer Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Anticancer Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Anticancer Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Teva Pharmaceuticals
2.7.1 Business Overview
2.7.2 Anticancer Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Teva Pharmaceuticals Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bayer
2.8.1 Business Overview
2.8.2 Anticancer Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bayer Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 GlaxoSmithKline
2.9.1 Business Overview
2.9.2 Anticancer Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GlaxoSmithKline Anticancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anticancer Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anticancer Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anticancer Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anticancer Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Anticancer Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anticancer Drug Market Analysis by Regions
4.1 Global Anticancer Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Anticancer Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anticancer Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Anticancer Drug Sales and Growth Rate (2013-2018)
4.3 Europe Anticancer Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anticancer Drug Sales and Growth Rate (2013-2018)
4.5 South America Anticancer Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anticancer Drug Sales and Growth Rate (2013-2018)
5 North America Anticancer Drug by Countries
5.1 North America Anticancer Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Anticancer Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anticancer Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Anticancer Drug Sales and Growth Rate (2013-2018)
5.3 Canada Anticancer Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Anticancer Drug Sales and Growth Rate (2013-2018)
6 Europe Anticancer Drug by Countries
6.1 Europe Anticancer Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Anticancer Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anticancer Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anticancer Drug Sales and Growth Rate (2013-2018)
6.3 UK Anticancer Drug Sales and Growth Rate (2013-2018)
6.4 France Anticancer Drug Sales and Growth Rate (2013-2018)
6.5 Russia Anticancer Drug Sales and Growth Rate (2013-2018)
6.6 Italy Anticancer Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anticancer Drug by Countries
7.1 Asia-Pacific Anticancer Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anticancer Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anticancer Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Anticancer Drug Sales and Growth Rate (2013-2018)
7.3 Japan Anticancer Drug Sales and Growth Rate (2013-2018)
7.4 Korea Anticancer Drug Sales and Growth Rate (2013-2018)
7.5 India Anticancer Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anticancer Drug Sales and Growth Rate (2013-2018)
8 South America Anticancer Drug by Countries
8.1 South America Anticancer Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Anticancer Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anticancer Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anticancer Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Anticancer Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Anticancer Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anticancer Drug by Countries
9.1 Middle East and Africa Anticancer Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anticancer Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anticancer Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anticancer Drug Sales and Growth Rate (2013-2018)
9.3 UAE Anticancer Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Anticancer Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Anticancer Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Anticancer Drug Sales and Growth Rate (2013-2018)
10 Global Anticancer Drug Market Segment by Type
10.1 Global Anticancer Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anticancer Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Anticancer Drug Revenue and Market Share by Type (2013-2018)
10.2 Targeted Drugs Sales Growth and Price
10.2.1 Global Targeted Drugs Sales Growth (2013-2018)
10.2.2 Global Targeted Drugs Price (2013-2018)
10.3 Cytotoxic Drugs Sales Growth and Price
10.3.1 Global Cytotoxic Drugs Sales Growth (2013-2018)
10.3.2 Global Cytotoxic Drugs Price (2013-2018)
10.4 Hormonal Drugs Sales Growth and Price
10.4.1 Global Hormonal Drugs Sales Growth (2013-2018)
10.4.2 Global Hormonal Drugs Price (2013-2018)
11 Global Anticancer Drug Market Segment by Application
11.1 Global Anticancer Drug Sales Market Share by Application (2013-2018)
11.2 Immunotherapy Sales Growth (2013-2018)
11.3 Targeted Therapy Sales Growth (2013-2018)
11.4 Chemotherapy Sales Growth (2013-2018)
11.5 Hormonal Therapy Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 Anticancer Drug Market Forecast (2018-2023)
12.1 Global Anticancer Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Anticancer Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Anticancer Drug Market Forecast (2018-2023)
12.2.2 Europe Anticancer Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anticancer Drug Market Forecast (2018-2023)
12.2.4 South America Anticancer Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anticancer Drug Market Forecast (2018-2023)
12.3 Anticancer Drug Market Forecast by Type (2018-2023)
12.3.1 Global Anticancer Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Anticancer Drug Market Share Forecast by Type (2018-2023)
12.4 Anticancer Drug Market Forecast by Application (2018-2023)
12.4.1 Global Anticancer Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Anticancer Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anticancer Drug Picture
Table Product Specifications of Anticancer Drug
Figure Global Sales Market Share of Anticancer Drug by Types in 2017
Table Antic
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
